FDA to speed reviews for drugs supporting ‘national interests’ A new pilot program announced by FDA Commissioner Martin Makary would award vouchers that could cut drug reviews to one or two months — ...

The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. | The FDA is introducing ...